Where is Memo Therapeutics headquartered?

Memo Therapeutics is located in Schlieren, zurich.

Who invested in Memo Therapeutics?

Memo Therapeutics has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has Memo Therapeutics raised to date?

Memo Therapeutics has raised ____.

When was the last funding round for Memo Therapeutics?

Memo Therapeutics closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

memo-therapeutics.com

Memo Therapeutics

Memo Therapeutics is a Switzerland-based biotechnology company that provides solutions such as antibody discovery and immune repository analysis for the healthcare sector.

Business Model:

Revenue: $1M

Employees: 11-50

Geographic Data

Address: Wagistrasse 27

City: Schlieren

State: zurich

Zip: 8952

Country: CH

Financial Info

Stage:

series b

Raised Last:

$25M

Raised Total:

$59M

Social

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Memo Therapeutics is a Switzerland-based biotechnology company that provides solutions such as antibody discovery and immune repository analysis for the healthcare sector.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
5/2018	Series A	4	$5M	Redalpine Zürcher Kantonal Bank Verve Ventures Schroder Adveq Redalpine
12/2021	Grant	1	$11.4M	Federal Office of Public Health (FOPH) Switzerland Federal Office of Public Health (FOPH) Switzerland
2/2022	Series B		$24.9M	Swisscanto Invest Adjuvant Capital GF Group Verve Ventures Vesalius Biocapital Zürcher Kantonalbank
11/2020	Series B		$15.4M	Swisscanto Invest BERNINA BioInvest Investiere Schroder Adveq Jaquet Partners Redalpine
11/2020	Series B	6	$15.6M	Bernina BioInvest Jaquet Partners Redalpine Schroder Adveq Swisscanto Private Equity Verve Ventures Bernina BioInvest Jaquet Partners Redalpine Schroder Adveq Swisscanto Private Equity Verve Ventures
7/2015	Series A	3	$2.3M	Zürcher Kantonal Bank Redalpine EVA Basel
2/2022	Series B		$0	Adjuvant Capital Fresenius Medical Care GF Group Holding Swisscanto Private Equity Verve Ventures Vesalius Biocapital Partners Zürcher Kantonal Bank Adjuvant Capital Fresenius Medical Care GF Group Holding Swisscanto Private Equity Verve Ventures Vesalius Biocapital Partners Zürcher Kantonal Bank
7/2015	Series A		$2.4M	Redalpine Zorcher Kantonalbank
5/2018	Series A		$5M	Redalpine Venture Partners Zurich Cantonal Bank
12/2021	Grant		$11.4M
2/2022	Series B	7	$24.9M	Adjuvant Capital Fresenius Medical Care GF Group Holding Swisscanto Private Equity Verve Ventures Vesalius Biocapital Partners Zürcher Kantonal Bank Adjuvant Capital Fresenius Medical Care GF Group Holding Swisscanto Private Equity Verve Ventures Vesalius Biocapital Partners Zürcher Kantonal Bank

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details